Stock Track | Omnicell Soars 14.84% After-Hours on Strong Revenue Guidance and Analyst Optimism

Stock Track

02/06

Omnicell's stock surged 14.84% in after-hours trading on Thursday, reversing earlier losses.

The healthcare technology company reported mixed fourth-quarter results but issued better-than-expected revenue guidance for the first quarter of 2026. While Q4 non-GAAP earnings per share fell short of analyst estimates, revenue slightly exceeded expectations. More importantly, the company projected Q1 revenue of $300 million to $310 million, well above the $281.5 million analysts had anticipated.

Additionally, analysts have recently provided insights on Omnicell, indicating optimism about the healthcare sector and the company's prospects. This combination of strong forward revenue guidance and positive analyst sentiment appears to have driven the after-hours rally.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1128671183"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1128671183\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1128671183?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 08:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128671183","market":"nz","top_or_hot":-1,"title":"Stock Track | Omnicell Soars 14.84% After-Hours on Strong Revenue Guidance and Analyst Optimism","media":"Stock Track","content":"<p>Omnicell's stock surged 14.84% in after-hours trading on Thursday, reversing earlier losses.</p><p>The healthcare technology company reported mixed fourth-quarter results but issued better-than-expected revenue guidance for the first quarter of 2026. While Q4 non-GAAP earnings per share fell short of analyst estimates, revenue slightly exceeded expectations. More importantly, the company projected Q1 revenue of $300 million to $310 million, well above the $281.5 million analysts had anticipated.</p><p>Additionally, analysts have recently provided insights on Omnicell, indicating optimism about the healthcare sector and the company's prospects. This combination of strong forward revenue guidance and positive analyst sentiment appears to have driven the after-hours rally.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Omnicell Soars 14.84% After-Hours on Strong Revenue Guidance and Analyst Optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Omnicell Soars 14.84% After-Hours on Strong Revenue Guidance and Analyst Optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-06 08:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Omnicell's stock surged 14.84% in after-hours trading on Thursday, reversing earlier losses.</p><p>The healthcare technology company reported mixed fourth-quarter results but issued better-than-expected revenue guidance for the first quarter of 2026. While Q4 non-GAAP earnings per share fell short of analyst estimates, revenue slightly exceeded expectations. More importantly, the company projected Q1 revenue of $300 million to $310 million, well above the $281.5 million analysts had anticipated.</p><p>Additionally, analysts have recently provided insights on Omnicell, indicating optimism about the healthcare sector and the company's prospects. This combination of strong forward revenue guidance and positive analyst sentiment appears to have driven the after-hours rally.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMCL","symbol_name":"Omnicell","start_time":0,"source_url":"","article_id":"1128671183","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128671183","pubTimestamp":1770339179,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Omnicell's stock surged 14.84% in after-hours trading on Thursday, reversing earlier losses.The healthcare technology company reported mixed fourth-quarter results but issued better-than-expected...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OMCL":"Omnicell"},"translate_title":"个股追踪|Omnicell盘后大涨14.84%，因强劲营收指引和分析师乐观","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMCL":1},"content_text":"Omnicell's stock surged 14.84% in after-hours trading on Thursday, reversing earlier losses.The healthcare technology company reported mixed fourth-quarter results but issued better-than-expected revenue guidance for the first quarter of 2026. While Q4 non-GAAP earnings per share fell short of analyst estimates, revenue slightly exceeded expectations. More importantly, the company projected Q1 revenue of $300 million to $310 million, well above the $281.5 million analysts had anticipated.Additionally, analysts have recently provided insights on Omnicell, indicating optimism about the healthcare sector and the company's prospects. This combination of strong forward revenue guidance and positive analyst sentiment appears to have driven the after-hours rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}